A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status

References

• Aeolus Pharmaceuticals. 2012. Aeolus Pharmaceuticals announces AEOL 10150 reduces lung damage after Neupogen treatment following radiation exposure. Mission Viejo (CA). Available at: http://www.aolsrx.com/news/press-releases/detail/924/aeolus-pharmaceuticals-announces-aeol-10150-reduces-lung [accessed 3 July 2014].
   Google Scholar
• Agarwal AB, McBride A. 2016. Understanding the biosimilar approval and extrapolation process – a case study of an epoetin biosimilar. Crit Rev Oncol Hematol. 104:98–107.
   PubMed Web of Science ®Google Scholar
• Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, Cher ML, Andic F, Rossi PJ, Kucuk O. 2010. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer. 62:996–1000.
   PubMed Web of Science ®Google Scholar
• Ainsworth EJ, Afzal SM, Crouse DA, Hanson WR, Fry RJ. 1989. Tissue responses to low protracted doses of high LET radiations or photons: early and late damage relevant to radio-protective countermeasures. Adv Space Res. 9:299–313.
   PubMedGoogle Scholar
• Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:5592–5595.
   PubMed Web of Science ®Google Scholar
• Ali BH, Al Moundhri MS. 2006. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol. 44:1173–1183.
   PubMed Web of Science ®Google Scholar
• American Thyroid Association. 2013. Nuclear radiation and the thyroid. Available at: http://www.thyroid.org/wp-content/uploads/patients/brochures/NuclearRadiation_brochure.pdf [accessed 1 Sept 2016].
   Google Scholar
• Atkinson K, Matias C, Guiffre A, Seymour R, Cooley M, Biggs J, Munro V, Gillis S. 1991. In vivo administration of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation. Blood. 77:1376–1382.
   PubMed Web of Science ®Google Scholar
• Batinic-Haberle I, Tovmasyan A, Roberts E, Vujaskovic Z, Leong KW, Spasojevic I. 2013. SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal. 20:2372–2415.
   PubMed Web of Science ®Google Scholar
• Beaulieu D. 2007. US government rejects Hollis-Eden’s Neumune proposal [Online]. FirstWorld Pharma. Available at: http://www.firstwordpharma.com/node/112458#axzz4hMkBsGLh [accessed 17 May 2017].
   Google Scholar
• Berbee M, Fu Q, Boerma M, Pathak R, Zhou D, Kumar KS, Hauer-Jensen M. 2011a. Reduction of radiation-induced vascular nitrosative stress by the vitamin E analog gamma-tocotrienol: evidence of a role for tetrahydrobiopterin. Int J Radiat Oncol Biol Phys. 79:884–891.
   PubMed Web of Science ®Google Scholar
• Berbee M, Fu Q, Boerma M, Wang J, Kumar KS, Hauer-Jensen M. 2009. Gamma-Tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism. Radiat Res. 171:596–605.
   PubMed Web of Science ®Google Scholar
• Berbee M, Fu Q, Garg S, Kulkarni S, Kumar KS, Hauer-Jensen M. 2011b. Pentoxifylline enhances the radioprotective properties of gamma-tocotrienol: differential effects on the hematopoietic, gastrointestinal and vascular systems. Radiat Res. 175:297–306.
   PubMed Web of Science ®Google Scholar
• Bourhis J, Rosine D. 2002. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Semin Oncol. 29:61–62.
   PubMed Web of Science ®Google Scholar
• Brizel DM. 2007. Pharmacologic approaches to radiation protection. J Clin Oncol. 25:4084–4089.
   PubMed Web of Science ®Google Scholar
• Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, et al. 2008. An agonist of Toll-like receptor 5 has radioprotective activity in mouse and primate models. Science. 320:226–230.
   PubMed Web of Science ®Google Scholar
• Burnett AF, Biju PG, Lui H, Hauer-Jensen M. 2013. Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model. Radiat Res. 180:595–602.
   PubMed Web of Science ®Google Scholar
• Caetano B, Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ. 2006. Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br J Nutr. 95:406–413.
   PubMed Web of Science ®Google Scholar
• Cai Y, Wang W, Liang H, Sun L, Teitelbaum DH, Yang H. 2013. Keratinocyte growth factor pretreatment prevents radiation-induced intestinal damage in a mouse model. Scand J Gastroenterol. 48:419–426.
   PubMed Web of Science ®Google Scholar
• Calveley VL, Khan MA, Yeung IW, Vandyk J, Hill RP. 2005. Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. Int J Radiat Biol. 81:887–899.
   PubMed Web of Science ®Google Scholar
• Cassatt DR, Fazenbaker CA, Bachy CM, Hanson MS. 2002. Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy. Semin Radiat Oncol. 12:97–102.
   PubMed Web of Science ®Google Scholar
• Cellerant Therapeutics. 2013. CLT-008 myeloid progenitor cells [Online]. Cellerant therapeutics; Available at: http://www.cellerant.com/ [accessed 4 July 2016].
   Google Scholar
• Centers for Disease Control and Prevention. 2016. Emergency preparedness and response. Available at: http://emergency.cdc.gov/radiation/countermeasures.asp [accessed 1 Sept 2016].
   Google Scholar
• Chirino YI, Pedraza-Chaverri J. 2009. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 61:223–242.
   PubMed Web of Science ®Google Scholar
• Clayton NP, Charpentier EJJ, LaCasse ER, Khan-Malek RC, Keutzer JM. 2016. Sargramostim significantly improved the mortality rate at Day 60 in a non-human primate model of hematopoietic acute radiation syndrome with minimal supportive care when administered 48 h after total body irradiation. Poster presented at: 42nd Conference of the European Radiation Research Society; Amsterdam, Netherlands.
   Google Scholar
• Cleveland BioLabs Inc. 2016. Entolimod (CBLB502) biodefense. Cleveland BioLabs, Inc. Available at: http://www.cbiolabs.com/ [accessed 10 June 2016].
   Google Scholar
• Comalada M, Ballester I, Bailon E, Sierra S, Xaus J, Galvez J, de Medina FS, Zarzuelo A. 2006. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol. 72:1010–1021.
   PubMed Web of Science ®Google Scholar
• Copp RR, Peebles DD, Soref CM, Fahl WE. 2013. Radioprotective efficacy and toxicity of a new family of aminothiol analogs. Int J Radiat Biol. 89:485–492.
   PubMed Web of Science ®Google Scholar
• Covic A, Abraham I. 2015. State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists. Int Urol Nephrol. 47:1529–1539.
   PubMed Web of Science ®Google Scholar
• Culy CR, Spencer CM. 2001. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs. 61:641–684.
   PubMed Web of Science ®Google Scholar
• Danilenko DM. 1999. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol. 27:64–71.
   PubMed Web of Science ®Google Scholar
• Davies J. 2007. U.S. won’t buy Hollis-Eden treatment for radiation. Union Turbine. Available at: http://legacy.sandiegouniontribune.com/news/business/biotech/20070317-9999-1b17hollis.html [accessed 17 May 2017].
   Google Scholar
• Davis TA, Clarke TK, Mog SR, Landauer MR. 2007. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. Int J Radiat Biol. 83:141–151.
   PubMed Web of Science ®Google Scholar
• Davis TA, Mungunsukh O, Zins S, Day RM, Landauer MR. 2008. Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol. 84:713–726.
   PubMed Web of Science ®Google Scholar
• Day R, Barshishat-Kupper M, Mog S, McCart E, Prasanna P, Davis T, Landauer M. 2008. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res. 49:361–372.
   PubMed Web of Science ®Google Scholar
• Day RM, Davis TA, Barshishat-Kupper M, McCart EA, Tipton AJ, Landauer MR. 2013. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. Int Immunopharmacol. 15:348–356.
   PubMed Web of Science ®Google Scholar
• Farese AM, Williams DE, Seiler FR, MacVittie TJ. 1993. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood. 82:3012–3018.
   PubMed Web of Science ®Google Scholar
• Farrell CL, Rex KL, Kaufman SA, Dipalma CR, Chen JN, Scully S, Lacey DL. 1999. Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol. 75:609–620.
   PubMed Web of Science ®Google Scholar
• Fendler W, Malachowska B, Meghani K, Konstantinopoulos PA, Guha C, Singh VK, Chowdhury D. 2017. Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates. Sci Transl Med. 9:eaal2408.
   PubMed Web of Science ®Google Scholar
• Finch PW, Mark Cross LJ, McAuley DF, Farrell CL. 2013. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models. J Cell Mol Med. 17:1065–1087.
   PubMed Web of Science ®Google Scholar
• Garofalo MC, Ward AA, Farese AM, Bennett A, Taylor-Howell C, Cui W, Gibbs A, Prado KL, Macvittie TJ. 2014. A pilot study in rhesus macaques to assess the treatment efficacy of a small molecular weight catalytic metalloporphyrin antioxidant (AEOL 10150) in mitigating radiation-induced lung damage. Health Phys. 106:73–83.
   PubMed Web of Science ®Google Scholar
• Georges GE, Kuver RP, Jordan R, Aragon A, Yang Y, Lesnikova M, Lesnikov V, Sale GE, McDonald GB. 2012. Post-exposure oral 17,21-beclomethasone dipropionate (BDP) improves survival in a canine gastrointestinal acute radiation syndrome (GI-ARS) model. Poster presented at: 58th Annual Meeting of the Radiation Research Society; San Juan (PR).
   Google Scholar
• Gerber SA, Cummings RJ, Judge JL, Barlow ML, Nanduri J, Johnson DE, Palis J, Pentland AP, Lord EM, Ryan JL. 2015. Interleukin-12 preserves the cutaneous physical and immunological barrier after radiation exposure. Radiat Res. 183:72–81.
   PubMed Web of Science ®Google Scholar
• Ghosh SP, Kulkarni S, Perkins MW, Hieber K, Pessu RL, Gambles K, Maniar M, Kao TC, Seed TM, Kumar KS. 2012. Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice. J Radiat Res. 53:526–536.
   PubMed Web of Science ®Google Scholar
• Ghosh SP, Pathak R, Kumar P, Biswas S, Bhattacharyya S, Kumar VP, Hauer-Jensen M, Biswas R. 2016. Gamma-tocotrienol modulates radiation-induced MicroRNA expression in mouse spleen. Radiat Res. 185:485–495.
   PubMed Web of Science ®Google Scholar
• Ghosh SP, Perkins MW, Hieber K, Kulkarni S, Kao TC, Reddy EP, Reddy MV, Maniar M, Seed T, Kumar KS. 2009. Radiation protection by a new chemical entity, ex-Rad: efficacy and mechanisms. Radiat Res. 171:173–179.
   PubMed Web of Science ®Google Scholar
• Gianoncelli A, Bonini SA, Bertuzzi M, Guarienti M, Vezzoli S, Kumar R, Delbarba A, Mastinu A, Sigala S, Spano P, et al. 2015. An integrated approach for a structural and functional evaluation of biosimilars: implications for erythropoietin. BioDrugs. 29:285–300.
   PubMed Web of Science ®Google Scholar
• Gluzman-Poltorak Z, Mendonca SR, Vainstein V, Kha H, Basile LA. 2014a. Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation. J Hematol Oncol. 7:31.
   PubMed Web of Science ®Google Scholar
• Gluzman-Poltorak Z, Vainstein V, Basile LA. 2014b. Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure. Am J Hematol. 89:868–873.
   PubMed Web of Science ®Google Scholar
• Gluzman-Poltorak Z, Vainstein V, Basile LA. 2015. Association of hematological nadirs and survival in a nonhuman primate model of hematopoietic syndrome of acute radiation syndrome. Radiat Res. 184:226–230.
   PubMed Web of Science ®Google Scholar
• Grace MB, Blakely WF, Landauer MR. 2007. Genistein-induced alterations of radiation-responsive gene expression. Radiat Measur. 42:1152–1157.
   Web of Science ®Google Scholar
• Grace MB, Singh VK, Rhee JG, Jackson WE 3rd, Kao TC, Whitnall MH. 2012. 5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis. J Radiat Res. 53:840–853.
   PubMed Web of Science ®Google Scholar
• Gridley DS, Makinde AY, Luo X, Rizvi A, Crapo JD, Dewhirst MW, Moeller BJ, Pearlstein RD, Slater JM. 2007. Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. Anticancer Res. 27:3101–3109.
   PubMed Web of Science ®Google Scholar
• Gudkov SV, Popova NR, Bruskov VI. 2015. Radioprotectors: history, trends and prospects. Biofizika. 60:801–811.
   PubMedGoogle Scholar
• Gupta S. 2013. FDA advisory committee meeting: Study drug Leukine. Available at: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/medicalimagingdrugsadvisorycommittee/ucm350156.pdf [accessed 2 Oct 2016].
   Google Scholar
• Ha CT, Li XH, Fu D, Xiao M, Landauer MR. 2013. Genistein nanoparticles protect mouse hematopoietic system and prevent proinflammatory factors after gamma irradiation. Radiat Res. 180:316–325.
   PubMed Web of Science ®Google Scholar
• Hammond WP, Boone TC, Donahue RE, Souza LM, Dale DC. 1990. A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF. Blood. 76:523–532.
   PubMed Web of Science ®Google Scholar
• Hauer-Jensen M. 2014. Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergencies. Dig Dis Sci. 59:1349–1351.
   PubMed Web of Science ®Google Scholar
• Health and Human Services. 2016. HHS enhances nation’s health preparedness for radiological threats. Available at: https://www.hhs.gov/about/news/2016/10/06/hhs-enhances-nation-s-health-preparedness-radiological-threats.html [accessed 20 Oct 2016].
   Google Scholar
• Henry M, Jackson Foundation for the Advancement of Military Medicine Inc., Kumar KS, Srinivasan V, Seed TM. 2004. Radiation protection by gamma-tocotrienol. PCT/US2002/004522; WO/2004/086412.
   Google Scholar
• Huang R, Yu H, Kuang A. 2002. Radioprotective effects on head and neck tumors of amifostine – a broad-spectrum cytoprotection. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 19:708–711.
   PubMedGoogle Scholar
• Humanetics Pharmaceuticals. 2016. BIO 300: development programs. Edina (MN): Humanetics Pharmaceuticals. Available at: http://humanetics.a03.neon.ittrium.com/development-programs [accessed 5 July 2016].
   Google Scholar
• Hussar DA. 2005. New drugs 05, part I. Nursing. 35:54–61.
   PubMedGoogle Scholar
• International Atomic Energy Agency (IAEA). 1988. The radiological accident in Goiânia. Available at: http://www-pub.iaea.org/MTCD/Publications/PDF/Pub815_web.pdf [accessed 2 Oct 2016].
   Google Scholar
• International Atomic Energy Agency (IAEA). 1990. The radiological accident in San Salvador. Available at: http://www-pub.iaea.org/books/IAEABooks/3718/The-Radiological-Accident-in-San-Salvador [accessed 20 Feb 2014].
   Google Scholar
• International Atomic Energy Agency (IAEA). 1993. The radiological accident in Soreq. Available at: http://www-pub.iaea.org/books/IAEABooks/3798/The-Radiological-Accident-in-Soreq [accessed 20 Feb 2014].
   Google Scholar
• International Atomic Energy Agency (IAEA). 1996. The radiological accident at the irradiation facility in Nesvizh. Available at: http://www-pub.iaea.org/books/IAEABooks/4712/The-Radiological-Accident-at-the-Irradiation-Facility-in-Nesvizh [accessed 10 Feb 2014].
   Google Scholar
• Jackson IL, Vujaskovic Z, Down JD. 2010. Revisiting strain-related differences in radiation sensitivity of the mouse lung: recognizing and avoiding the confounding effects of pleural effusions. Radiat Res. 173:10–20.
   PubMed Web of Science ®Google Scholar
• Jackson IL, Vujaskovic Z, Down JD. 2011. A further comparison of pathologies after thoracic irradiation among different mouse strains: finding the best preclinical model for evaluating therapies directed against radiation-induced lung damage. Radiat Res. 175:510–518.
   PubMed Web of Science ®Google Scholar
• Jackson IL, Xu P, Hadley C, Katz BP, McGurk R, Down JD, Vujaskovic Z. 2012. A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule. Health Phys. 103:463–473.
   PubMed Web of Science ®Google Scholar
• Johnke RM, Sattler JA, Allison RR. 2014. Radioprotective agents for radiation therapy: future trends. Future Oncol. 10:2345–2357.
   PubMed Web of Science ®Google Scholar
• Kang AD, Cosenza SC, Bonagura M, Manair M, Reddy MV, Reddy EP. 2013. ON01210.Na (Ex-RAD®) mitigates radiation damage through activation of the AKT pathway. PLoS One. 8:e58355.
   PubMed Web of Science ®Google Scholar
• Karacetin D, Yucel B, Leblebicioglu B, Aksakal O, Maral O, Incekara O. 2004. A randomized trial of amifostine as radioprotector in the radiotherapy of head and neck cancer. BUON. 9:23–26.
   PubMedGoogle Scholar
• Kazzi ZN, Heyl A, Ruprecht J. 2012. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241. Curr Pharm Biotechnol. 13:1957–1963.
   PubMed Web of Science ®Google Scholar
• Kehlet RA, Robinson SI, Young RW, Feister A. 1996. Selection of a drug for prevention of radiation-induced nausea and vomiting. In: Reeves GI, Jarrett DG, Seed TM, King GL, Blakely WF, editors. Triage of irradiated personnel. Armed forces radiobiology research institute workshop. Bethesda, MD: Armed Forces Radiobiology Research Institute.
   Google Scholar
• Kim H, Peterson TG, Barnes S. 1998. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor b signaling pathways. Am J Clin Nutr. 68S:1418S–1425S.
   Google Scholar
• Koukourakis MI, Panteliadou M, Abatzoglou IM, Sismanidou K, Sivridis E, Giatromanolaki A. 2013. Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection. Int J Radiat Oncol Biol Phys. 85:e7–13.
   PubMed Web of Science ®Google Scholar
• Krivokrysenko VI, Shakhov AN, Singh VK, Bone F, Kononov Y, Shyshynova I, Cheney A, Maitra RK, Purmal A, Whitnall MH, et al. 2012. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J Pharmacol Exp Ther. 343:497–508.
   PubMed Web of Science ®Google Scholar
• Krivokrysenko VI, Toshkov IA, Gleiberman AS, Krasnov P, Shyshynova I, Bespalov I, Maitra RK, Narizhneva NV, Singh VK, Whitnall MH, et al. 2015. The Toll-like receptor 5 agonist Entolimod mitigates lethal acute radiation syndrome in non-human primates. PLoS One. 10:e0135388.
   PubMed Web of Science ®Google Scholar
• Kruk I, Aboul-Enein HY, Michalska T, Lichszteld K, Kladna A. 2005. Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein. Luminescence. 20:81–89.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Singh PK, Ghosh SP, Posarac A, Singh VK. 2013. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. Cytokine. 62:278–285.
   PubMed Web of Science ®Google Scholar
• Kumar KS, Papas A, Seed TM, Srinivasan V. 2006. Radiation protection by gamma-tocotrienol. USA Patent application PCT/US2004/00452.
   Google Scholar
• Landauer MR, Srinivasan V, Seed TM. 2003. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol. 23:379–385.
   PubMed Web of Science ®Google Scholar
• Lauritano D, Petruzzi M, Di Stasio D, Lucchese A. 2014. Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study. Int J Oral Sci. 6:27–30.
   PubMed Web of Science ®Google Scholar
• Liu Q, Jiang B, Jiang LP, Wu Y, Wang XG, Zhao FL, Fu BH, Istvan T, Jiang E. 2008. Clinical report of three cases of acute radiation sickness from a (60)Co radiation accident in Henan Province in China. JRR. 49:63–69.
   PubMed Web of Science ®Google Scholar
• Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ, Dexter TM. 1991. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood. 77:2154–2159.
   PubMed Web of Science ®Google Scholar
• Loria RM, Conrad DH, Huff T, Carter H, Ben-Nathan D. 2000. Androstenetriol and androstenediol. Protection against lethal radiation and restoration of immunity after radiation injury. Ann NY Acad Sci. 917:860–867.
   PubMed Web of Science ®Google Scholar
• MacVittie TJ, Monroy RL, Farese AM, Seiler FR, Williams D. 1991. Cytokine therapy in canine and primate models of radiation-induced marrow aplasia. Behring Inst Mitt. 90:1–13.
   Google Scholar
• MacVittie TJ, Farese AM, Smith WG, Baum CM, Burton E, McKearn JP. 2000. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood. 95:837–845.
   PubMed Web of Science ®Google Scholar
• Mahmood J, Jelveh S, Calveley V, Zaidi A, Doctrow SR, Hill RP. 2011. Mitigation of radiation-induced lung injury by genistein and EUK-207. Int J Radiat Biol. 87:889–901.
   PubMed Web of Science ®Google Scholar
• Monroy RL, Davis TA, MacVittie TJ. 1990. Granulocyte-macrophage colony-stimulating factor: more than a hemopoietin. Clin Immunol Immunopathol. 54:333–346.
   PubMedGoogle Scholar
• Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ. 1988. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 16:344–348.
   PubMed Web of Science ®Google Scholar
• Murigi FN, Mohindra P, Hung C, Salimi S, Goetz W, Pavlovic R, Jackson IL, Vujaskovic Z. 2015. Dose optimization study of AEOL 10150 as a mitigator of radiation-induced lung injury in CBA/J mice. Radiat Res. 184:422–432.
   PubMed Web of Science ®Google Scholar
• Nabholtz JM, Cantin J, Chang J, Guevin R, Patel R, Tkaczuk K, Vodvarka P, Lindsay MA, Reese D, Riva A, et al. 2002. Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. Clin Breast Cancer. 3:268–275.
   PubMedGoogle Scholar
• Nagayama H, Misawa K, Tanaka H, Ooi J, Iseki T, Tojo A, Tani K, Yamada Y, Kodo H, Takahashi TA, et al. 2002. Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim. Bone Marrow Transplant. 29:197–204.
   PubMed Web of Science ®Google Scholar
• Nash RA, Schuening FG, Seidel K, Appelbaum FR, Boone T, Deeg HJ, Graham TC, Hackman R, Sullivan-Pepe M, Storb R. 1994. Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 83:1963–1970.
   PubMed Web of Science ®Google Scholar
• National Institute of Allergic and Infectious Diseases. 2015. Pegfilgrastim approved for treating acute radiation syndrome. Available at: https://www.niaid.nih.gov/topics/radnuc/Pages/pegfilgrastim.aspx [accessed 18 Aug 2016].
   Google Scholar
• Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G. 1997. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood. 90:2565–2573.
   PubMed Web of Science ®Google Scholar
• Neumedicines. 2014. HemaMax™ (rHuIL-12) for acute radiation syndrome. Pasadena, CA: Neumedicines. Available at: http://www.neumedicines.com/ [accessed 27 Oct 2014].
   Google Scholar
• Nothdurft W, Selig C, Fliedner TM, Hintz-Obertreis P, Kreja L, Krumwieh D, Kurrle R, Seiler FR, Weinsheimer W. 1992. Haematological effects of rhGM-CSF in dogs exposed to total-body irradiation with a dose of 2.4 Gy. Int J Radiat Biol. 61:519–531.
   PubMed Web of Science ®Google Scholar
• Oki T, Sowa Y, Hirose T, Takagaki N, Horinaka M, Nakanishi R, Yasuda C, Yoshida T, Kanazawa M, Satomi Y, et al. 2004. Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Lett. 577:55–59.
   PubMed Web of Science ®Google Scholar
• Orrell RW. 2006. AEOL-10150 (Aeolus). Curr Opin Investig Drugs. 7:70–80.
   PubMed Web of Science ®Google Scholar
• Para AE, Bezjak A, Yeung IW, Van Dyk J, Hill RP. 2009. Effects of genistein following fractionated lung irradiation in mice. Radiother Oncol. 92:500–510.
   PubMed Web of Science ®Google Scholar
• Patchen ML, Fischer R, MacVittie TJ, Seiler FR, Williams DE. 1993. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects. Biotherapy. 7:13–26.
   PubMedGoogle Scholar
• Pathak R, Bachri A, Ghosh SP, Koturbash I, Boerma M, Binz RK, Sawyer JR, Hauer-Jensen M. 2016. The vitamin E analog gamma-tocotrienol (GT3) suppresses radiation-induced cytogenetic damage. Pharm Res. 33:2117–2125.
   PubMed Web of Science ®Google Scholar
• Pearlstein RD, Higuchi Y, Moldovan M, Johnson K, Fukuda S, Gridley DS, Crapo JD, Warner DS, Slater JM. 2010. Metalloporphyrin antioxidants ameliorate normal tissue radiation damage in rat brain. Int J Radiat Biol. 86:145–163.
   PubMed Web of Science ®Google Scholar
• Peebles DD, Soref CM, Copp RR, Thunberg AL, Fahl WE. 2012. ROS-scavenger and radioprotective efficacy of the new PrC-210 aminothiol. Radiat Res. 178:57–68.
   PubMed Web of Science ®Google Scholar
• Potten CS. 1995. Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation. Int J Cancer. 62:356–361.
   PubMed Web of Science ®Google Scholar
• Potten CS. 1996. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells. 14:452–459.
   PubMed Web of Science ®Google Scholar
• Praetorius NP, Mandal TK. 2008. Alternate delivery route for amifostine as a radio-/chemo-protecting agent. J Pharm Pharmacol. 60:809–815.
   PubMed Web of Science ®Google Scholar
• Reeves G. 2014. Overview of use of G-CSF and GM-CSF in the treatment of acute radiation injury. Health Phys. 106:699–703.
   PubMed Web of Science ®Google Scholar
• Sanofi-aventis U.S. LLC. 2013. Leukine. Available at: http://products.sanofi.us/Leukine/Leukine.html [accessed 20 Oct 2016].
   Google Scholar
• Santini V. 2001. Amifostine: chemotherapeutic and radiotherapeutic protective effects. Expert Opin Pharmacother. 2:479–489.
   PubMedGoogle Scholar
• Schuchter LM. 1996. Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol). Eur J Cancer. 32A(Suppl.4):S40–S42.
   PubMed Web of Science ®Google Scholar
• Seed TM. 2005. Radiation protectants: current status and future prospects. Health Phys. 89:531–545.
   PubMed Web of Science ®Google Scholar
• Seed TM, Inal CE, Singh VK. 2014. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis. Int J Radiat Biol. 90:594–604.
   PubMed Web of Science ®Google Scholar
• Selig C, Nothdurft W, Kreja L, Fliedner TM. 1991. Influence of combined treatment with interleukin 1 and erythropoietin or GM-CSF and erythropoietin on the regeneration of hemopoiesis in the dog after total body irradiation – a preliminary report. Behring Inst Mitt. 90:86–92.
   Google Scholar
• Singh VK, Christensen J, Fatanmi OO, Gille D, Ducey EJ, Wise SY, Karsunky H, Sedello AK. 2012a. Myeloid progenitors: A radiation countermeasure that is effective when initiated days after irradiation. Radiat Res. 177:781–791.
   PubMed Web of Science ®Google Scholar
• Singh VK, Ducey EJ, Brown DS, Whitnall MH. 2012b. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol. 88:296–310.
   PubMed Web of Science ®Google Scholar
• Singh VK, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Seed TM. 2016a. The potentiation of the radioprotective efficacy of two medical countermeasures, gamma-tocotrienol and amifostine, by a combination prophylactic modality. Radiat Prot Dosimetry. 172:302–310.
   PubMed Web of Science ®Google Scholar
• Singh VK, Hauer-Jensen M. 2016. Gamma-tocotrienol as a promising countermeasure for acute radiation syndrome: Current status. IJMS. 17:e663.
   Web of Science ®Google Scholar
• Singh VK, Kulkarni S, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Hendrickson H, Gulani J, Ghosh SP, Kumar KS, et al. 2016b. Radioprotective efficacy of gamma-tocotrienol in nonhuman primates. Radiat Res. 185:285–298.
   PubMed Web of Science ®Google Scholar
• Singh VK, Newman VL, Seed TM. 2015a. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review. Cytokine. 71:22–37.
   PubMed Web of Science ®Google Scholar
• Singh VK, Olabisi AO. 2017. Nonhuman primates as models for the discovery and development of radiation countermeasures. Expert Opin Drug Discov. 12:695–709.
   PubMed Web of Science ®Google Scholar
• Singh VK, Romaine PL, Newman VL, Seed TM. 2016c. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents. Expert Opin Ther Pat. 26:1399–1408.
   PubMed Web of Science ®Google Scholar
• Singh VK, Romaine PL, Seed TM. 2015b. Medical countermeasures for radiation exposure and related injuries: Characterization of medicines, FDA-approval status and inclusion into the Strategic National Stockpile. Health Phys. 108:607–630.
   PubMed Web of Science ®Google Scholar
• Singh VK, Shafran RL, Inal CE, Jackson WE 3rd, Whitnall MH. 2005. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol Immunotoxicol. 27:521–534.
   PubMed Web of Science ®Google Scholar
• Soligenix Inc. 2016. OrbeShield™ for gastrointestinal acute radiation syndrome (GI ARS). Princeton, NJ: Soligenix, Inc. Available at: http://www.soligenix.com/pipeline/vaccinesbiodefense/orbeshield-for-gastrointestinal-acute-radiation-syndrome-gi-ars/ [accessed 10 July 2016].
   Google Scholar
• Soref CM, Hacker TA, Fahl WE. 2012. A new orally active, aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses. Int J Radiat Oncol Biol Phys. 82:e701–e707.
   PubMed Web of Science ®Google Scholar
• Stickney DR, Dowding C, Authier S, Garsd A, Onizuka-Handa N, Reading C, Frincke JM. 2007. 5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol. 7:500–505.
   PubMed Web of Science ®Google Scholar
• Stickney DR, Dowding C, Garsd A, Ahlem C, Whitnall M, McKeon M, Reading C, Frincke J. 2006. 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol. 6:1706–1713.
   PubMed Web of Science ®Google Scholar
• Stickney DR, Groothuis JR, Ahlem C, Kennedy M, Miller BS, Onizuka-Handa N, Schlangen KM, Destiche D, Reading C, Garsd A, et al. 2010. Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndrome. J Radiol Prot. 30:687–698.
   PubMed Web of Science ®Google Scholar
• Suman S, Datta K, Chakraborty K, Kulkarni SS, Doiron K, Fornace AJ Jr, Sree Kumar K, Hauer-Jensen M, Ghosh SP. 2013. Gamma tocotrienol, a potent radioprotector, preferentially upregulates expression of anti-apoptotic genes to promote intestinal cell survival. Food Chem Toxicol. 60:488–496.
   PubMed Web of Science ®Google Scholar
• Suman S, Datta K, Doiron K, Ren C, Kumar R, Taft DR, Fornace AJ Jr, Maniar M. 2012a. Radioprotective effects of ON 01210.Na upon oral administration. J Radiat Res. 53:368–376.
   PubMed Web of Science ®Google Scholar
• Suman S, Maniar M, Fornace AJ Jr, Datta K. 2012b. Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response. Radiat Oncol. 7:6.
   PubMed Web of Science ®Google Scholar
• Tacyildiz N, Ozyoruk D, Yavuz G, Unal E, Dincaslan H, Dogu F, Sahin K, Kucuk O. 2010. Soy isoflavones ameliorate the adverse effects of chemotherapy in children. Nutr Cancer. 62:1001–1005.
   PubMed Web of Science ®Google Scholar
• Tamulevicius P, Wang M, Iliakis G. 2007. Homology-directed repair is required for the development of radioresistance during S phase: interplay between double-strand break repair and checkpoint response. Radiat Res. 167:1–11.
   PubMed Web of Science ®Google Scholar
• Tanikawa S, Nakao I, Tsuneoka K, Nara N. 1989. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice. Exp Hematol. 17:883–888.
   PubMed Web of Science ®Google Scholar
• The Radiation Emergency Assistance Center/Training Site. 2013. The medical aspects of radiation incidents. Available at: https://orise.orau.gov/files/reacts/medical-aspects-of-radiation-incidents.pdf [accessed 28 Oct 2016].
   Google Scholar
• U.S. Department of Health & Human Services. 2013. HHS boosts stockpile of products to treat acute radiation syndrome. Available at: http://www.hhs.gov/news/press/2013pres/09/20130926a.html [accessed 12 Feb 2014].
   Google Scholar
• U.S. Food and Drug Administration. 2015. FDA approves Neupogen for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident. Silver Spring (MD): U.S. Food and Drug Administration. Available at: http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/ucm443245.htm [accessed 6 July 2016].
   Google Scholar
• Vadhan-Raj S, Goldberg JD, Perales MA, Berger DP, van den Brink MR. 2013. Clinical applications of palifermin: amelioration of oral mucositis and other potential indications. J Cell Mol Med. 17:1371–1384.
   PubMed Web of Science ®Google Scholar
• Valachovicova T, Slivova V, Sliva D. 2004. Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem. 4:881–887.
   PubMed Web of Science ®Google Scholar
• van der Vijgh WJ, Peters GJ. 1994. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects. Semin Oncol. 21:2–7.
   PubMed Web of Science ®Google Scholar
• Vasin MV, Antipov VV, Chernov GA, L’Vova TS, Koroleva LV, Semenova LA, Liutykh VP, Komarova SN, Gaidamakin NA, Vilkina GA. 1996. Studies of the radiation-protective effects of indralin on the hematopoietic system of different species of animals. Radiats Biol Radioecol. 36:168–189.
   PubMedGoogle Scholar
• Vasin MV, Semenov LF, Suvorov NN, Antipov VV, Ushakov IB, Ilyin LA, Lapin BA. 2014. Protective effect and the therapeutic index of indralin in juvenile rhesus monkeys. J Radiat Res. 55:1048–1055.
   PubMed Web of Science ®Google Scholar
• Waddick KG, Song CW, Souza L, Uckun FM. 1991. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood. 77:2364–2371.
   PubMed Web of Science ®Google Scholar
• Wasserman TH, Brizel DM. 2001. The role of amifostine as a radioprotector. Oncology (Williston Park, NY). 15:1349–1354.
   PubMed Web of Science ®Google Scholar
• Whitcomb RC Jr, Ansari AJ, Buzzell JJ, McCurley MC, Miller CW, Smith JM, Evans DL. 2015. A public health perspective on the U.S. response to the Fukushima radiological emergency. Health Phys. 108:357–363.
   PubMed Web of Science ®Google Scholar
• Whitnall MH, Elliott TB, Harding RA, Inal CE, Landauer MR, Wilhelmsen CL, McKinney L, Miner VL, Jackson WE 3rd, Loria RM, et al. 2000. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int J Immunopharmacol. 22:1–14.
   PubMed Web of Science ®Google Scholar
• Whitnall MH, Villa V, Seed TM, Benjack J, Miner V, Lewbart ML, Dowding CA, Jackson WE 3rd. 2005. Molecular specificity of 5-androstenediol as a systemic radioprotectant in mice. Immunopharmacol Immunotoxicol. 27:1–18.
   PubMed Web of Science ®Google Scholar
• Whitnall MH, Wilhelmsen CL, McKinney L, Miner V, Seed TM, Jackson WE 3rd. 2002. Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol Immunotoxicol. 24:595–626.
   PubMed Web of Science ®Google Scholar
• Wu HJ, Chan WH. 2007. Genistein protects methylglyoxal-induced oxidative DNA damage and cell injury in human mononuclear cells. Toxicol in Vitro. 21:335–342.
   PubMed Web of Science ®Google Scholar
• Yamamoto LG. 2013. Risks and management of radiation exposure. Pediatr Emerg Care. 29:1016–1026.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X, Rabbani ZN, Jackson IL, Vujaskovic Z. 2012. Oxidative stress mediates radiation lung injury by inducing apoptosis. Int J Radiat Oncol Biol Phys. 83:740–748.
   PubMed Web of Science ®Google Scholar